VisEn rolls out VivoTag

Optical imaging developer VisEn Medical of Bedford, MA, has launched its new VivoTag 680 XL fluorescent dye for labeling biomolecules in a broad range of in vitro and in vivo imaging applications.

VivoTag 680 XL is designed for more efficient labeling of target molecules under standard research conditions and is optimized for in vivo and cell-based imaging, including enhanced brightness, biocompatibility, and stability in biologic environments.

Related Reading

VisEn buys rights to fluorescence agents, January 28, 2010

VisEn launches imaging agent, January 19, 2010

VisEn debuts new molecular imaging agents, November 20, 2009

VisEn debuts molecular agent, FMT systems, September 24, 2009

VisEn launches fluorescence agent, September 2, 2009

Copyright © 2010 AuntMinnie.com

Page 1 of 3458
Next Page